Search on this blog

Search on this blog

Call for abstracts · IFFI 2027

Share your research
with the world.

We welcome clinicians, researchers and healthcare professionals to submit original research, case studies, systematic reviews and innovative findings in women's health, fertility and reproductive medicine. Accepted abstracts are considered for oral and poster presentation at IFFI 2027 — advancing the science and practice of reproductive medicine from the UAE to the world.

Submission deadline29 Nov 2026
Review & notification10 Dec 2026
Abstract lengthMax 350 words
Per participantUp to 2 abstracts
Submission guidelines

Before you submit.

Maximum 350 words

Count the body of the abstract only — title, authors and keywords are not included in the limit.

Structured format

Title · Authors & affiliations (with presenting author and corresponding email) · Objective · Methods · Results · Conclusions · 3–5 keywords.

English only

Abstracts must be written in clear scientific English. Define all abbreviations on first use.

Online submission only

Submit through the online form. Abstracts sent by fax or email will not be accepted.

Up to two abstracts per participant

Each participant may submit a maximum of two abstracts; only one is eligible for oral presentation.

Register to present

Presenting authors of accepted abstracts must be registered for the conference.

Abstract structureIn this order
  1. TitleConcise and specific, no abbreviations
  2. Authors & affiliationsPresenting author marked, corresponding email included
  3. ObjectiveWhat question the study answers
  4. MethodsDesign, population, interventions, analysis
  5. ResultsKey findings with data
  6. ConclusionsWhat it means for practice
  7. Keywords3 – 5 keywords
Word limit350 words
Topics of interest

Ten tracks. One stage.

We welcome submissions in, but not limited to, the following areas. Open a track to see its topics.

  • Embryo culture systems and embryo development
  • Cryopreservation and vitrification advances
  • Oocyte and embryo quality optimization
  • Preimplantation Genetic Testing (PGT-A, PGT-M, PGT-SR)
  • IVF laboratory quality control and safety
  • Individualized ovarian stimulation protocols
  • Poor ovarian responders and POSEIDON classification
  • Ovarian aging and advanced maternal age
  • Recurrent implantation failure and recurrent pregnancy loss
  • ART outcome optimization strategies
  • Endometrial receptivity assessment
  • Thin endometrium management
  • Reproductive immunology and uterine microbiome
  • Male factor infertility evaluation and management
  • Advanced sperm selection technologies (IMSI, MACS, microfluidics)
  • Sperm DNA fragmentation and epigenetics
  • Surgical sperm retrieval techniques
  • Oncology fertility preservation
  • Social egg freezing and elective preservation
  • Fertility preservation in medical and genetic conditions
  • Pediatric and adolescent fertility preservation
  • Ovarian tissue cryopreservation and transplantation
  • AI in embryo assessment and IVF decision-making
  • Machine learning prediction models in ART outcomes
  • Digital IVF laboratories and automation
  • Big data registries and outcome analytics
  • Telemedicine and digital fertility platforms
  • Hysteroscopic fertility surgery
  • Laparoscopic fertility surgery
  • Robotic reproductive surgery
  • Surgical management of endometriosis and adenomyosis
  • Tubal surgery and uterine reconstruction
  • Prenatal diagnosis and genetic screening after ART
  • Multiple pregnancy management
  • Fetal growth restriction and placental disorders
  • Congenital anomalies and ART pregnancies
  • Advanced fetal imaging and interventions
  • PCOS and endocrine disorders affecting fertility
  • Fibroids and fertility outcomes
  • Uterine cavity abnormalities (polyps, adhesions, septum)
  • Endometriosis and adenomyosis in ART patients
  • Lifestyle, metabolism, and environmental factors
  • Early pregnancy complications after IVF
  • Obstetric complications after ART (pre-eclampsia, preterm birth, placenta disorders)
  • Ethics, law, ART add-ons, and patient-centred fertility care
  • Fertility-sparing treatment in gynecologic oncology
  • Oncofertility counselling in cancer care
  • Impact of chemotherapy and radiotherapy on ovarian function
  • Assisted reproduction after gynecologic cancer treatment
  • Pregnancy after gynecologic cancer
  • Reproductive outcomes after cancer therapy
  • Ovarian function and menstrual recovery after treatment

Not sure which track fits? Choose the closest one — the scientific committee may reassign abstracts to the most suitable session.

Presentation formats

Oral or poster.

Oral presentations

Selected abstracts are invited for a 10-minute presentation followed by a live Q&A with the experts, in front of an international audience.

10 min talk + Q&A

Poster presentations

Accepted posters are displayed in dedicated poster sessions, giving authors the opportunity to discuss their work with delegates and faculty.

Dedicated poster sessions
Be part of it

A global platform for innovation & science.

Questions about your submission? info@irada.ae · +971 55 998 1999